HomeMarket NewsFriday 5/17 Insider Buying Report: ALTI, TRDA

Friday 5/17 Insider Buying Report: ALTI, TRDA

Actionable Trade Ideas

always free

As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy β€” they expect to make money. So let’s look at two noteworthy recent insider buys.

At AlTi Global, a filing with the SEC revealed that on Thursday, President, Asset Management Timothy F. Keaney bought 84,210 shares of ALTI, for a cost of $4.56 each, for a total investment of $383,702. So far Keaney is in the green, up about 5.4% on their purchase based on today’s trading high of $4.80. AlTi Global is trading up about 2% on the day Friday. This buy marks the first one filed by Keaney in the past year.

And on Tuesday, Director Peter S. Kim bought $364,672 worth of Entrada Therapeutics, buying 25,000 shares at a cost of $14.59 a piece. Before this latest buy, Kim bought TRDA at 4 other times during the past twelve months, for a total cost of $213,961 at an average of $13.46 per share. Entrada Therapeutics is trading up about 1.3% on the day Friday. Kim was up about 5.2% on the purchase at the high point of today’s trading session, with TRDA trading as high as $15.34 at last check today.

Friday 5/17 Insider Buying Report: ALTI, TRDAVIDEO: Friday 5/17 Insider Buying Report: ALTI, TRDA

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Swing Trading Ideas and Market Commentary

Need some new swing ideas? Get free weekly swing ideas and market commentary from Jonathan Bernstein here: Swing Trading.

Explore More

Weekly In-Depth Market Analysis and Actionable Trade Ideas

Get institutional-level analysis and trade ideas to take your trading to the next level, sign up for free and become apart of the community.